Medicenna Therapeutics Corp's total assets for Q4 2024 were C$28.38M, a decrease of -11.96% from the previous quarter. TSE:MDNA total liabilities were C$9.29M for the fiscal quarter, a -37.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.